Rantanen V - Search Results

1

Pelvic floor disorders and health-related quality of life in older women: Results from the Women's Gynaecological Health study in Lieto, Finland.

Eloranta S, Rantanen V, Kauppila M, Hautaniemi S, Vahlberg T, Laasik M, Joronen K, Sintonen H, Ala-Nissilä S. Eloranta S, et al. Among authors: rantanen v. Arch Gerontol Geriatr. 2019 May-Jun;82:226-231. doi: 10.1016/j.archger.2019.03.001. Epub 2019 Mar 2. Arch Gerontol Geriatr. 2019. PMID: 30875524

2

A Mayer-Rokitansky-Kuster-Hauser patient with leiomyoma and dysplasia of neovagina: a case report.

Jokimaa V, Virtanen J, Kujari H, Ala-Nissilä S, Rantanen V. Jokimaa V, et al. Among authors: rantanen v. BMC Womens Health. 2020 Jul 28;20(1):157. doi: 10.1186/s12905-020-01026-1. BMC Womens Health. 2020. PMID: 32723331 Free PMC article.

3

High-dose chemotherapy with autologous stem cell support for the treatment of advanced ovarian cancer--initial experience in Uppsala and Turku.

Grenman S, Tholander B, Remes K, Kauppila M, Rajamäki A, Pelliniemi TT, Rantanen V, Salmi T, Carlsson K, Hóglund M, Oberg G, Simonson B, Salmi T. Grenman S, et al. Among authors: rantanen v. Acta Obstet Gynecol Scand. 1997 Apr;76(4):363-8. doi: 10.1111/j.1600-0412.1997.tb07994.x. Acta Obstet Gynecol Scand. 1997. PMID: 9174433 Free article. Review.

4

High-risk human papillomavirus associated with incident cervical intraepithelial neoplasia developing in mothers in the Finnish Family HPV Study cohort.

Rintala MA, Louvanto K, Rantanen V, Grénman SE, Syrjänen KJ, Syrjänen SM. Rintala MA, et al. Among authors: rantanen v. Scand J Infect Dis. 2012 Feb;44(2):115-25. doi: 10.3109/00365548.2011.619999. Epub 2011 Nov 6. Scand J Infect Dis. 2012. PMID: 22053923

5

High-dose chemotherapy with autologous stem cell support in advanced ovarian cancer.

Grénman SE, Rantanen VT, Salmi TA. Grénman SE, et al. Among authors: rantanen vt. Ann Med. 1996 Apr;28(2):151-8. doi: 10.3109/07853899609092940. Ann Med. 1996. PMID: 8732644 Review.

6

The role of cul-de-sac aspiration cytology in the follow-up of ovarian cancer.

Engblom PR, Grènman SE, Klemi PJ, Hirvonen TE, Rantanen VT, Salmi TA. Engblom PR, et al. Among authors: rantanen vt. Acta Oncol. 1995;34(6):783-5. doi: 10.3109/02841869509127187. Acta Oncol. 1995. PMID: 7576746

7

PAP smear after radiation therapy for cervical carcinoma.

Rintala MA, Rantanen VT, Salmi TA, Klemi PJ, Grénman SE. Rintala MA, et al. Among authors: rantanen vt. Anticancer Res. 1997 Sep-Oct;17(5B):3747-50. Anticancer Res. 1997. PMID: 9427773

8

Operative treatment of advanced cervical cancer after full pelvic irradiation.

Leino R, Grénman S, Rantanen V, Kiilholma P, Salmi T. Leino R, et al. Among authors: rantanen v. Ann Chir Gynaecol Suppl. 1994;208:50-3. Ann Chir Gynaecol Suppl. 1994. PMID: 8092773

9

Comparative evaluation of cisplatin and carboplatin sensitivity in endometrial adenocarcinoma cell lines.

Rantanen V, Grénman S, Kulmala J, Grénman R. Rantanen V, et al. Br J Cancer. 1994 Mar;69(3):482-6. doi: 10.1038/bjc.1994.87. Br J Cancer. 1994. PMID: 8123477 Free PMC article.

10

Endometrial cancer cell lines are sensitive to paclitaxel.

Rantanen V, Grénman S, Kulmala J, Grénman R. Rantanen V, et al. Anticancer Res. 1996 Jan-Feb;16(1):475-9. Anticancer Res. 1996. PMID: 8615657

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

95 results

Search Page